1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 7:Comparison of Known-Group Validity (Discrimination of 28 Patients with AD from 28 Control Subjects) with Linear and Volumetric MR-Based Measures of MTL Atrophy in the MR Group
Control Group AD Group Sensitivity (95% CI)* Mean Crude Measure ± SD (mm) Mean Crude Measure ± SD (mm) Mean W-score ± SD Radial width of the temporal horn (mm) Right 3.7 ± 1.1 6.7 ± 2.0 3.0 ± 1.9 76% (56%–89%) Left 3.3 ± 1.5 5.8 ± 2.5 1.7 ± 1.6 51% (32%–70%) Largest 4.1 ± 1.2 7.2 ± 2.1 2.7 ± 1.7 73% (53%–87%) Coronal width of the temporal horn (mm) Right 3.0 ± 1.2 5.3 ± 2.3 2.4 ± 2.3 63% (43%–80%) Left 3.2 ± 1.1 6.1 ± 2.3 3.4 ± 2.7 74% (54%–88%) Largest 3.4 ± 1.2 6.5 ± 2.3 2.7 ± 2.1 69% (49%–84%) Hippocampal volume (mm3) Right 1951 ± 335 1309 ± 361 1.7 ± 1.2 52% (33%–71%) Left 1797 ± 288 1263 ± 344 1.7 ± 1.0 52% (33%–71%) Smallest 1774 ± 282 1191 ± 336 2.3 ± 1.2 71% (51%–86%)
Note.—P < .0005 for difference between groups on t test for all measures. W scores are age-standardized values, that is, the number of SD away from the age-specific atrophy value of control subjects (control W scores, 0 ± 1.0). Greater absolute values indicate greater atrophy.
* Values computed by modeling W scores of Patients with AD and control subjects with specificity set at 95%.